Dr Reddy's denied permission to conduct Phase-3 trials for Sputnik Light in India
India's drug controller has denied permission to Dr Reddy's to conduct phase-3 trials of the Russian-made single-dose Sputnik Light Covid-19 vaccine in India. The application is said to have been taken up for discussion on Wednesday.
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of the Sputnik V coronavirus vaccine.
Earlier, reports in June had said that Dr Reddy's in talks with the central government for a speedy launch of the Sputnik Light vaccine in India.
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of the Sputnik V coronavirus vaccine.
Earlier, reports in June had said that Dr Reddy's in talks with the central government for a speedy launch of the Sputnik Light vaccine in India.